Cargando…

Skin and gastrointestinal symptoms in COVID-19

INTRODUCTION: The first cases of coronavirus disease 2019 (COVID-19) were noted in December 2019 in Wuhan province, China. The World Health Organisation (WHO) announced the pandemic status on March 11, 2020. The manifestations of the disease are as follows: fever, cough, fatigue, anosmia and ageusia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ciechanowicz, Piotr, Lewandowski, Konrad, Szymańska, Elżbieta, Kaniewska, Magdalena, Rydzewska, Grażyna M., Walecka, Irena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2020
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988824/ https://www.ncbi.nlm.nih.gov/pubmed/33777269 http://dx.doi.org/10.5114/pg.2020.101558

Ejemplares similares

Gastrointestinal symptoms in COVID-19
por: Lewandowski, Konrad, et al.
Publicado: (2022)

Gastrointestinal symptoms in patients with coronavirus disease 2019 (COVID-19) – friend or foe?
por: Lewandowski, Konrad, et al.
Publicado: (2021)

The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome
por: Lewandowski, Konrad, et al.
Publicado: (2022)

Does smoking affect your skin?
por: Lipa, Katarzyna, et al.
Publicado: (2021)

Long-lasting dyspeptic symptoms – another consequence of the COVID-19 pandemic?
por: Nazarewska, Anna, et al.
Publicado: (2023)

Cutaneous manifestations of coronavirus disease 2019 – review of literature and case reports
por: Ciechanowicz, Piotr, et al.
Publicado: (2020)

The Use of Virtual Reality to Reduce Stress among Inflammatory Bowel Disease Patients Treated with Vedolizumab
por: Lewandowski, Konrad, et al.
Publicado: (2021)

Dermatological manifestations of the Coronavirus disease 2019 in children: a systemic review
por: Ciechanowicz, Piotr, et al.
Publicado: (2020)

Low-FODMAP Diet for the Management of Irritable Bowel Syndrome in Remission of IBD
por: Więcek, Martyna, et al.
Publicado: (2022)

The Role of Epigenetic Factors in Psoriasis
por: Dopytalska, Klaudia, et al.
Publicado: (2021)

Hidradenitis suppurativa – biologic therapy and other available treatment options
por: Lipa, Katarzyna, et al.
Publicado: (2022)

The efficacy and safety of the biosimilar product (Inflectra(®)) compared to the reference drug (Remicade(®)) in rescue therapy in adult patients with ulcerative colitis
por: Kaniewska, Magdalena, et al.
Publicado: (2017)

Selected Aspects of Nutrition in the Prevention and Treatment of Inflammatory Bowel Disease
por: Panufnik, Paulina, et al.
Publicado: (2022)

Effective treatment of severe acute pancreatitis and COVID-19 pneumonia with tocilizumab
por: Zielecki, Piotr, et al.
Publicado: (2020)

Elastography as a possible useful method of assessment of skin involvement in systemic sclerosis
por: Sobolewski, Piotr, et al.
Publicado: (2021)

Biosimilar infliximab versus originator in Crohn’s disease anti-TNF-α naïve and non-naïve patients
por: Kaniewska, Magdalena, et al.
Publicado: (2020)

Effectiveness of Crohn’s Disease Exclusion Diet for Induction of Remission in Crohn’s Disease Adult Patients
por: Szczubełek, Martyna, et al.
Publicado: (2021)

Reply to van Lingen et al. Comment on “Szczubełek et al. Effectiveness of Crohn’s Disease Exclusion Diet for Induction of Remission in Crohn’s Disease Adult Patients. Nutrients 2021, 13, 4112”
por: Szczubełek, Martyna, et al.
Publicado: (2022)

Skin manifestations of neuroendocrine neoplasms: review of the literature
por: Walecka, Irena, et al.
Publicado: (2022)

Psychological consequences of hospital isolation during the COVID-19 pandemic - research on the sample of polish firefighting academy students
por: Walecka, Irena, et al.
Publicado: (2021)

How to perform high ultrasound examination of skin involvement among patients with systemic sclerosis – proposition of a unified protocol
por: Sobolewski, Piotr, et al.
Publicado: (2021)

The introduction of the IBD Disk in Poland – a new tool for assessing disability in patients with inflammatory bowel disease
por: Eder, Piotr, et al.
Publicado: (2019)

Risk Factors for Osteoporosis among Patients with Inflammatory Bowel Disease—Do We Already Know Everything?
por: Lewandowski, Konrad, et al.
Publicado: (2023)

The Essential Role of microRNAs in Inflammatory and Autoimmune Skin Diseases—A Review
por: Dopytalska, Klaudia, et al.
Publicado: (2023)

Psoriasis in special localizations
por: Dopytalska, Klaudia, et al.
Publicado: (2018)

Biosimilar biological drugs in the treatment of inflammatory bowel diseases
por: Kaniewska, Magdalena, et al.
Publicado: (2019)

Preparation for endoscopic examinations in patients with diabetes and hypoglycaemia
por: Lewandowski, Konrad, et al.
Publicado: (2021)

Management of anaemia in patients with inflammatory bowel disease – results of a questionnaire among Polish healthcare professionals
por: Tulewicz-Marti, Edyta M., et al.
Publicado: (2021)

Systemic sclerosis and the gastrointestinal tract
por: Walecka, Irena
Publicado: (2017)

Familial localized scleroderma with paediatric onset: a review
por: Yurtsever, Ida, et al.
Publicado: (2021)

Iron deficiency anaemia in patients with inflammatory bowel disease: National Consultant for Gastroenterology Working Group Recommendations
por: Kaniewska, Magdalena, et al.
Publicado: (2014)

Diet as therapeutic intervention in Crohn’s disease
por: Więcek, Martyna, et al.
Publicado: (2022)

Selected personality traits and emotional disorders of women diagnosed with gastrointestinal disease – a pilot study
por: Piotrowicz, Grażyna, et al.
Publicado: (2022)

Effectiveness of infliximab biosimilars in the treatment of moderate to severe chronic plaque psoriasis: experience of real-world data from the register of the program “Treatment of moderate and severe forms of plaque psoriasis (B.47)” of the National Health Fund in Poland
por: Owczarek, Witold, et al.
Publicado: (2021)

The effect of cyclic rifaximin therapy on symptoms of diverticular disease from the perspective of the gastroenterology outpatient clinic: a “real-life” study
por: Moniuszko, Andrzej, et al.
Publicado: (2017)

Systemic sclerosis – multidisciplinary disease: clinical features and treatment
por: Sobolewski, Piotr, et al.
Publicado: (2019)

Bone Metabolism Alteration in Patients with Inflammatory Bowel Disease
por: Tulewicz-Marti, Edyta Maria, et al.
Publicado: (2022)

Exocrine pancreatic insufficiency and causes of abdominal symptoms in diabetes patients
por: Kadaj-Lipka, Roland, et al.
Publicado: (2020)

Approach to endoscopic procedures during COVID-19 pandemic – not as expected
por: Ratyński, Tomasz, et al.
Publicado: (2020)

The position statement of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology regarding the management of patients with inflammatory bowel disease during the COVID-19 pandemic
por: Łodyga, Michał, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_30nc5voejuoa883v8bh44sqn2u